Center For Molecular Medicine Offers New Test For Colorectal Cancer
GRAND RAPIDS - The Center for Molecular Medicine announced it is one of the first laboratories in the nation to offer a new test to help guide the treatment of metastatic colorectal cancer. The CMM is offering the CellSearch System from Veridex to physicians as a vital new tool in managing patients with metastatic CRC.